WCN24-243 SEVERE RELAPSING NEPHROTIC SYNDROME DUE TO MINIMAL CHANGE DISEASE SECONDARY TO NAPROXEN INTAKE: A CASE REPORT
Saved in:
| Main Author: | Rami El Fishawy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924011513 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
WCN24-1921 NEPHROTIC SYNDROME SECONDARY AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS DUE TO PODOCYTE KANK-2 MUTATION
by: Sandra Liliana Borda Galindo, et al.
Published: (2024-04-01) -
WCN24-1037 Minimal change glomerulonephritis steroid-dependent nephrotic syndrome treated with Rituximab
by: FABRIZIO CRISTIANO
Published: (2024-04-01) -
WCN24-2162 ROLE OF RITUXIMAB IN LONG TERM REMISSION OF IDIOPATHIC STEROID DEPENDENT & FREQUENTLY RELAPSING CHILDHOOD ONSET NEPHROTIC SYNDROME
by: ARJUN RAY, et al.
Published: (2024-04-01) -
WCN24-164 Genetic Screening in Children with Challenging Nephrotic Syndrome
by: Mohamad Bassam Said
Published: (2024-04-01) -
Naproxen: A universal analgesic with a minimal risk of cardiovascular events
by: A. E. Karateev
Published: (2016-06-01)